{"id":"CHEMBL1060","canonicalSmiles":"O=P([O-])([O-])O.[Na+].[Na+]","inchiKey":"BNIILDVGGAEEIG-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PHOSPHATE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Neutral sod phos"],"synonyms":["E-339(II)","FEMA NO. 2398","INS NO.339(II)","INS-339(II)","Sodium orthophosphate","Sodium phosphate","Sodium phosphate dibasic","Sodium phosphate, dibasic anhydrous","Sodium phosphate, dibasic, anhydrous","Sodium phosphate, unspecified"],"crossReferences":{"DailyMed":["sodium%20phosphate","sodium%20phosphate,%20dibasic,%20anhydrous"],"DrugCentral":["4219"],"Wikipedia":["Disodium_phosphate"],"drugbank":["DB14502"],"chEBI":["34683"]},"childChemblIds":["CHEMBL2107560","CHEMBL2107525"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for constipation and has 2 investigational indications."}
{"id":"CHEMBL109","canonicalSmiles":"CCCC(CCC)C(=O)O","inchiKey":"NIJJYAXOARWZEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VALPROIC ACID","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Convulex","Depakene","Depakote","Stavzor","Valproic acid"],"synonyms":["44089","NSC-93819","Pentanoic acid, 2-propyl","Valproate","Valproic acid","Valproic acid extended release"],"crossReferences":{"DailyMed":["divalproex%20sodium","valproate%20sodium","valproic%20acid"],"PubChem":["144204642","144209161","144210920","170465446","17389523","26752921","399407","90341449"],"TG-GATEs":["5"],"Wikipedia":["Valproic_acid"],"drugbank":["DB00313"],"chEBI":["39867"]},"childChemblIds":["CHEMBL2315212","CHEMBL2105613","CHEMBL433"],"linkedTargets":{"rows":["ENSG00000112294"],"count":1},"linkedDiseases":{"rows":["EFO_0008525","EFO_0004777","EFO_0001075","EFO_0000756","EFO_0003015","EFO_1001951","EFO_0000565","EFO_0000309","EFO_0000339","MONDO_0002974","MONDO_0008903","MONDO_0004976","HP_0002121","EFO_0008526","EFO_0002618","EFO_0005762","EFO_0000198","EFO_1000877","EFO_0003888","HP_0002039","MONDO_0008170","EFO_0000180","EFO_0003758","EFO_0002939","EFO_1001968","MONDO_0015643","MONDO_0021144","Orphanet_783","MONDO_0008315","EFO_1001918","Orphanet_791","EFO_0000546","MP_0001914","Orphanet_399","EFO_0004192","EFO_0005800","EFO_0003841","EFO_0000574","MONDO_0004979","HP_0031273","MONDO_0021640","EFO_0009878","MONDO_0037255","MONDO_0005090","MONDO_0100342","HP_0000726","MONDO_0007254","EFO_0004252","EFO_0009267","EFO_1001469","MONDO_0001187","Orphanet_68380","MONDO_0005277","EFO_0004247","EFO_0000474","EFO_0000289","EFO_0009430","Orphanet_683","MONDO_0002050","EFO_0000326","EFO_0003761","EFO_0002499","HP_0002013","MONDO_0007079","EFO_0005230","EFO_0000717","EFO_0007527","MONDO_0003478","EFO_1000158","EFO_0000616","EFO_0006859","HP_0010865","EFO_0000403","EFO_0000222","EFO_0009963","EFO_0001358","HP_0001250","Orphanet_64280","EFO_0001073","EFO_0003060","EFO_0000311","EFO_1000140","HP_0000713","Orphanet_368","Orphanet_83419","EFO_0000095","EFO_0000764","MONDO_0004975","EFO_0000702","EFO_0005611","MONDO_0043510","Orphanet_3463","EFO_0003833","EFO_0000691","EFO_0000519","EFO_0000181","EFO_0004191","EFO_0005411"],"count":98},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and has 12 approved and 81 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL113690","canonicalSmiles":"CCCCn1c(Cc2cc(OC)c(OC)c(OC)c2)nc2c(N)ncnc21","inchiKey":"TUOSCZDRWRYPRS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL113690","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02754"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1159717","canonicalSmiles":"CC(C)(C)NCC(O)c1ccccc1Cl","inchiKey":"YREYLAVBNPACJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TULOBUTEROL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brelomax","Respacal"],"synonyms":["Atenos","Berachin","Bremax","Chlibamol","Hokunalin","Lobuterol","NSC-758643","Tulobuterol","Tulobuterol hcl","Tulobuterol hydrochloride"],"crossReferences":{"PubChem":["90340621"],"Wikipedia":["Tulobuterol"],"drugbank":["DB12248"]},"childChemblIds":["CHEMBL1256478"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["HP_0006536","MONDO_0004979","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for airway obstruction."}
{"id":"CHEMBL1159973","canonicalSmiles":"CCCCCCCCOC[C@H](COP(=O)(O)OCCN)OP(=O)(O)CCCCCCC","inchiKey":"RCCNUBYROFOKAU-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1159973","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03565"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1186610","canonicalSmiles":"CCCC(CCC)C(=O)O[C@@H]1C[C@@H]2CC[C@H](C1)[N+]2(C)C","inchiKey":"XGGHHHBGPSNXFE-ZSHCYNCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANISOTROPINE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Anisotropine","Octatropine"],"crossReferences":{"PubChem":["50103910","50103911"],"Wikipedia":["Octatropine_methylbromide"]},"childChemblIds":["CHEMBL1578"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL118722","canonicalSmiles":"CCCC(=O)OCC(COC(=O)CCC)OC(=O)CCC","inchiKey":"UYXTWWCETRIEDR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIBUTYRIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Butyrin","FEMA NO. 2223","NSC-661583","Tributyrin"],"crossReferences":{"PubChem":["509766"],"drugbank":["DB12709"],"chEBI":["35020"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1200388","canonicalSmiles":"Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]","inchiKey":"KCUWTKOTPIUBRI-VICXVTCVSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOXACILLIN SODIUM","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL891","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cloxacillin sodium","Cloxapen","Dariclox","Ekvacillin","Orbenin","Tegopen"],"synonyms":["BRL-1621","Cloxacillin (as sodium)","Cloxacillin sodium","Cloxacillin sodium hydrate","Cloxacillin sodium salt monohydrate","Cloxypen","Ekvacillin","Latocillin","Methocillin-s","P-25","Sodium cloxacillin monohydrate"],"crossReferences":{"PubChem":["57264344"],"chEBI":["34978"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 3 investigational indications."}
{"id":"CHEMBL1200395","canonicalSmiles":"Cc1ccccc1C(OCCN(C)C)c1ccccc1.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"MMMNTDFSPSQXJP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORPHENADRINE CITRATE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL900","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Norflex","Orphenadrine citrate"],"synonyms":["NSC-757238","Orphenadine citrate","Orphenadrine (citrate)","Orphenadrine Citrate","Orphenadrine citrate","Orphenadrine dihydrogen citrate"],"crossReferences":{"DailyMed":["orphenadrine%20citrate"],"PubChem":["11532864","144204876","144207092","144211396","170464910","26748176"],"chEBI":["7790"]},"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000103546","ENSG00000116032","ENSG00000136546","ENSG00000198785","ENSG00000168356","ENSG00000007314","ENSG00000196876","ENSG00000185313","ENSG00000161509","ENSG00000183873","ENSG00000144285","ENSG00000105464","ENSG00000169432","ENSG00000196639","ENSG00000176884","ENSG00000136531","ENSG00000153253"],"count":19},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and is indicated for pain."}
{"id":"CHEMBL1200532","canonicalSmiles":"CN1CCC(CN2c3ccccc3Sc3ccccc32)C1.Cl","inchiKey":"IEISBKIVLDXSMZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHDILAZINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200959","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Methdilazine hydrochloride","Tacaryl"],"synonyms":["Methdilazine hcl","Methdilazine hydrochloride","NSC-169091"],"crossReferences":{"PubChem":["144203598","562732"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200718","canonicalSmiles":"[Mg+2].[OH-].[OH-]","inchiKey":"VTHJTEIRLNZDEV-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIA, [MILK OF]","yearOfFirstApproval":2000,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cremaffin","Crm of magnesia","Hydro-Magna","Magnalax","Mil-par","Milk of magnesia","Mint-o-mag","Oxaine m","Phillips magnesia tablets","Phillips milk of magnesia","Phillips milk of magnesia liquid"],"synonyms":["E-528","E528","INS NO.528","INS-528","Magnesia magma","Magnesia, [milk of]","Magnesii hydroxidum","Magnesium (as hydroxide)","Magnesium hydroxide"],"crossReferences":{"DailyMed":["magnesium%20hydroxide"],"Wikipedia":["Magnesium_hydroxide"],"drugbank":["DB09104"],"chEBI":["6637"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2000 and is indicated for constipation disorder."}
{"id":"CHEMBL1200825","canonicalSmiles":"CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1.Cl","inchiKey":"FJQXCDYVZAHXNS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHADONE HYDROCHLORIDE","yearOfFirstApproval":1947,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL651","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dolophine hydrochloride","Eptadone","Martindale","Methadone hydrochloride","Methadone hydrochloride intensol","Methadose","Metharose","Methex","Physeptone","Pinadone","Synastone","Westadone"],"synonyms":["AN-148","Butalgin","Dolofin hydrochloride","Dolophine","Fenadone","Heptadon","Ketalgin hydrochloride","Mecodin","Methadone hcl","Methadone hydrochloride","Methadone hydrochloride cii","Methadonium chloride","NSC-19600","Phenadone hydrochloride"],"crossReferences":{"DailyMed":["methadone%20hydrochloride"],"PubChem":["144206448","144209224","144210950"],"chEBI":["50140"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["MONDO_0000726","EFO_0003890","EFO_0000764","EFO_0005611","HP_0008419","EFO_0003843","EFO_1001951"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1947 and has 3 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200861","canonicalSmiles":"O=C(O)[C@@H](O)[C@H](O)C(=O)O","inchiKey":"FEWJPZIEWOKRBE-LWMBPPNESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARTARIC ACID","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["E334","Tartaric acid"],"crossReferences":{"PubChem":["4253871","49648471"],"Wikipedia":["Tartaric_acid"],"drugbank":["DB01694"],"chEBI":["15672"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985."}
{"id":"CHEMBL1200927","canonicalSmiles":"CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1.O=C(O)/C=C\\C(=O)O","inchiKey":"DBAKFASWICGISY-DASCVMRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXCHLORPHENIRAMINE MALEATE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201353","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dexchlorpheniramine maleate","Mylaramine","Polaramine"],"synonyms":["Chlorpheniramine d-form maleate","Chlorpheniramine maleate, (s)-","D-chlorpheniramine maleate","Dexchlorpheniramine maleate","NSC-759156"],"crossReferences":{"DailyMed":["dexchlorpheniramine%20maleate"],"PubChem":["26747471","26747472","49681543","50106017"],"drugbank":["DB09555"],"chEBI":["4465"]},"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0005531","MONDO_0005301","EFO_0003958","EFO_0007533","MONDO_0005271","MONDO_0024352","EFO_0007141","EFO_0005532","EFO_1001417","MONDO_0008315","EFO_0003956"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 8 approved and 2 investigational indications."}
{"id":"CHEMBL1201041","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+]","inchiKey":"UVOCNBWUHNCKJM-XFAPPKAWSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"AZLOCILLIN SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1537","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Azlin","Securopen"],"synonyms":["Azlocillin sodium","Azlocillin sodium salt","BAY-E 6905","BAY-E-6905"],"crossReferences":{"chEBI":["51864"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201056","canonicalSmiles":"CCn1ccc(NS(=O)(=O)c2ccc(N)cc2)nc1=O","inchiKey":"SIBQAECNSSQUOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFACYTINE","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Renoquid"],"synonyms":["CI-636","NSC-356717","Sulfacitine","Sulfacytine"],"crossReferences":{"PubChem":["170465286"],"Wikipedia":["Sulfacytine"],"drugbank":["DB01298"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1975."}
{"id":"CHEMBL1201067","canonicalSmiles":"CC(O)C(=O)O.OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2","inchiKey":"GLPUBCPQWZZFNJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIPERIDEN LACTATE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1101","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Akineton"],"synonyms":["Biperiden lactate"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["MONDO_0043510"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961 and has 1 investigational indication."}
{"id":"CHEMBL1201269","canonicalSmiles":"CC(C)(N)Cc1ccc(Cl)cc1","inchiKey":"ZCKAMNXUHHNZLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORPHENTERMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Germany"],"classes":["Cardiotoxicity"],"year":1969},"tradeNames":[],"synonyms":["Chlorphentermine"],"crossReferences":{"PubChem":["29216103"],"Wikipedia":["Chlorphentermine"],"drugbank":["DB01556"],"chEBI":["3646"]},"childChemblIds":["CHEMBL1200595"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982. It was withdrawn in Germany  in 1969 due to Cardiotoxicity."}
{"id":"CHEMBL1201379","canonicalSmiles":"O=C(O)CCC/C=C\\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/[C@@H](O)COc1cccc(C(F)(F)F)c1","inchiKey":"WWSWYXNVCBLWNZ-QIZQQNKQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPROSTENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluoprostenol","Fluprostenol","ICI-81008"],"crossReferences":{"PubChem":["144205331","26754611","29216067"],"drugbank":["DB11519"],"chEBI":["60782"]},"childChemblIds":["CHEMBL2107435"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1201589","drugType":"Antibody","blackBoxWarning":true,"name":"OMALIZUMAB","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xolair"],"synonyms":["CT-P39","Ct-p39","Hs632","IGE25","OLIZUMAB","Omalizumab","RG-3648","RHUMAB-E25"],"crossReferences":{"DailyMed":["omalizumab"],"DrugCentral":["4972"],"Wikipedia":["Omalizumab"]},"linkedTargets":{"rows":["ENSG00000211891"],"count":1},"linkedDiseases":{"rows":["Orphanet_2314","EFO_0007486","EFO_0007425","EFO_0008507","MONDO_0005271","EFO_0000274","MONDO_0021063","EFO_0000540","EFO_0005531","EFO_0002690","EFO_1001881","EFO_0005854","EFO_0009661","EFO_0003818","EFO_0005532","MONDO_0004784","EFO_0009482","MONDO_0001085","EFO_0007187","EFO_0004232","HP_0006536","EFO_1000685","EFO_1001463","MONDO_0100096","EFO_1001890","MONDO_0004979","EFO_0000341","EFO_0003956","EFO_0007369"],"count":29},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and has 3 approved and 22 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1204644","canonicalSmiles":"CN(CC(=O)O)C(=N)NP(=O)(O)O","inchiKey":"DRBBFCLWYRJSJZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFOCREATINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Creatine phosphate","Creatine-p","Fosfocreatine","Phosphagen","Phosphocreatine"],"crossReferences":{"drugbank":["DB13191"],"chEBI":["17287"]},"childChemblIds":["CHEMBL7649"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1221657","canonicalSmiles":"NCc1ccc(C(=O)N2CCC3(CC2)N=C(N)c2c(F)cccc2N3)cc1","inchiKey":"SFPCNWQWKOUNRT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1221657","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08750"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229214","canonicalSmiles":"CC[N+]1(CC)CCC(=C(c2ccccc2)c2ccccc2)C1C","inchiKey":"ZYEPZINLLPPBMI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRIFINIUM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Prifinium cation","Prifinium ion"],"crossReferences":{"drugbank":["DB13254"]},"childChemblIds":["CHEMBL1213353"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1231871","canonicalSmiles":"O=C=O","inchiKey":"CURLTUGMZLYLDI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBON DIOXIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbon Dioxide","Carbon dioxide","Carbonic acid","Dry ice (solid form)","E-290","E290","INS NO.290","INS-290","NSC-81688"],"crossReferences":{"Wikipedia":["Carbon_dioxide"],"drugbank":["DB09157"],"chEBI":["16526"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL1232461","canonicalSmiles":"CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c2cc(OC)ccc2-n2c(C)nnc21","inchiKey":"AAAQFGUYHFJNHI-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOLIBRESIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bet inhibitor gsk525762","GSK-525762","GSK-525762A","GSK525762","GSK525762A","I-BET 762","Molibresib"],"childChemblIds":["CHEMBL4297217"],"linkedTargets":{"rows":["ENSG00000169925","ENSG00000204256","ENSG00000137948","ENSG00000141867"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000313"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1243","canonicalSmiles":"Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1","inchiKey":"PBCZLFBEBARBBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFABENZAMIDE","yearOfFirstApproval":1945,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-74587","Sulfabenzamide","Sulfabenzamide (triple sulfa)","Triple sulfa (sulfabenzamide)"],"crossReferences":{"PubChem":["11112278","144203961","170465133","26746972","855720"],"Wikipedia":["Sulfabenzamide"],"drugbank":["DB09355"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1945."}
{"id":"CHEMBL124718","canonicalSmiles":"C[C@](O)(COc1ccc(F)cc1)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1","inchiKey":"KJMFOTCDISOHDX-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL124718","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07769"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1256987","canonicalSmiles":"CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\\CCC=C(C)C)C(=O)[O-].[Na+]","inchiKey":"HJHVQCXHVMGZNC-JCJNLNMISA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FUSIDATE SODIUM","maximumClinicalTrialPhase":4,"parentId":"CHEMBL374975","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fucidine"],"synonyms":["Fucidin","Fucidin leo","Fusidate sodium","Fusidic Acid Sodium","Fusidic acid sodium salt","Fusidic acid, sodium salt","SQ 16360","SQ-16360","Sodium fusidate","ZN-6"],"crossReferences":{"PubChem":["144204296","57260077"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1259059","canonicalSmiles":"CC(C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@](C)(F)[C@@H]1O)Oc1ccccc1","inchiKey":"TTZHDVOVKQGIBA-IQWMDFIBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"SOFOSBUVIR","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Psi-7977, gs-7977","Sovaldi"],"synonyms":["GS-7977","GS7977","PSI-7977","Sofosbuvir"],"crossReferences":{"DailyMed":["sofosbuvir"],"drugbank":["DB08934"],"chEBI":["85083"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 3 approved and 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1490","canonicalSmiles":"OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1","inchiKey":"HWHLPVGTWGOCJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIHEXYPHENIDYL","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Apo-trihex","NSC-12268","Trihexyphenidyl"],"crossReferences":{"DailyMed":["trihexyphenidyl%20hydrochloride"],"PubChem":["50105266","90341555"],"Wikipedia":["Trihexyphenidyl"],"drugbank":["DB00376"],"chEBI":["9720"]},"childChemblIds":["CHEMBL1092"],"linkedTargets":{"rows":["ENSG00000168539"],"count":1},"linkedDiseases":{"rows":["MONDO_0003441","MONDO_0005180","EFO_1000632","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1949 and is indicated for parkinson disease and has 1 investigational indication."}
{"id":"CHEMBL1512677","canonicalSmiles":"CCCCCc1ccc(C)cc1O","inchiKey":"CKGWFZQGEQJZIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMYLMETACRESOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Throaties"],"synonyms":["6-n-amyl-m-cresol","Amylmetacresol"],"crossReferences":{"PubChem":["144206204","50125738"],"drugbank":["DB13908"],"chEBI":["48213"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1589793","canonicalSmiles":"CCN(CC)c1ccc(C(=C2C=CC(=[N+](CC)CC)C=C2)c2ccccc2)cc1","inchiKey":"HXCILVUBKWANLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1589793","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["29217881"],"drugbank":["DB11279"],"chEBI":["88176"]},"childChemblIds":["CHEMBL1790039"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1677","canonicalSmiles":"Cl.Nc1c2c(nc3ccccc13)CCCC2","inchiKey":"ZUFVXZVXEJHHBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TACRINE HYDROCHLORIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL95","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Alzyme","Cognex"],"synonyms":["CI-970","NSC-72108","Tacrine hcl","Tacrine hydrochloride"],"crossReferences":{"PubChem":["11532943","144207497","17388697","26747422","49732004","50105756"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993."}
{"id":"CHEMBL1742989","drugType":"Antibody","blackBoxWarning":false,"name":"BAVITUXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bavituximab","CH3G4","TARVACIN"],"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 14 investigational indications."}
{"id":"CHEMBL1902981","canonicalSmiles":"CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1","inchiKey":"SQUNAWUMZGQQJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPERISONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eperisone","Eperisone hydrochloride"],"crossReferences":{"PubChem":["50113017"],"Wikipedia":["Eperisone"],"drugbank":["DB08992"],"chEBI":["77070"]},"childChemblIds":["CHEMBL2360601"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1908904","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc(F)cc1)C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(N)=O)[C@@H](C)O)C(C)C)C(C)C","inchiKey":"LXFYUKLDFCXXMA-ZIKCCIOVSA-N","drugType":"Protein","blackBoxWarning":false,"name":"FBA-A20FMDV2","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL504111"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL204394","canonicalSmiles":"Oc1ccc2c(O)cccc2c1","inchiKey":"FZZQNEVOYIYFPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Naphthalene-1,6-Diol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Naphthalene-1,6-Diol"],"crossReferences":{"drugbank":["DB07661"],"chEBI":["42040"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105646","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)CN)C(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C","inchiKey":"ORFLZNAGUTZRLQ-ZMBVWFSWSA-N","drugType":"Protein","blackBoxWarning":false,"name":"LARAZOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-2347","Larazotide"],"crossReferences":{"drugbank":["DB05645"]},"childChemblIds":["CHEMBL2103815"],"linkedTargets":{"rows":["ENSG00000080644","ENSG00000117971"],"count":2},"linkedDiseases":{"rows":["EFO_0001060"],"count":1},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105659","canonicalSmiles":"CCc1c(C(=O)C(N)=O)c2c(OCC(=O)OC)cccc2n1Cc1ccccc1","inchiKey":"VJYDOJXJUCJUHL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VARESPLADIB METHYL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-002","LY-333013","LY333013","S-3013","Varespladib methyl","Varespladib methyl ester"],"crossReferences":{"drugbank":["DB05737"]},"linkedTargets":{"rows":["ENSG00000069764","ENSG00000188257","ENSG00000127472"],"count":3},"linkedDiseases":{"rows":["EFO_0003086","EFO_0001645","EFO_0005672"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105834","canonicalSmiles":"C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@H](CO)[C@@H](C)O)NC1=O.O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O","inchiKey":"KFWJVABDRRDUHY-XJQYZYIXSA-N","drugType":"Protein","blackBoxWarning":false,"name":"OCTREOTIDE PAMOATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1680","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Octreotide embonate","Octreotide pamoate","SMS 201-995 PA","SMS PA","SMS-201-995 PA","SMS-PA"],"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2106155","canonicalSmiles":"COc1ccc(C(=O)Nc2ccccc2CCC2CCCCN2C)cc1.Cl","inchiKey":"OJIIZIWOLTYOBS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCAINIDE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL315838","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"],"classes":["Cardiotoxicity"],"year":1991},"tradeNames":["Enkaid"],"synonyms":["Encainide hcl","Encainide hydrochloride","MJ 9067-1","MJ-9067","MJ-9067-1"],"crossReferences":{"PubChem":["144207047"],"chEBI":["59880"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986. It was withdrawn in United Kingdom and  United States initially in 1991 due to Cardiotoxicity."}
{"id":"CHEMBL2106794","canonicalSmiles":"NC(=O)N/N=C1\\C=Cc2ccccc2C1=O","inchiKey":"TZGBBMBARSFJBG-UKTHLTGXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFTAZONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Mediavan"],"synonyms":["Haemostop injection","Karbinon","Mediaven","Naftazone"],"crossReferences":{"drugbank":["DB13680"]},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL2107862","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"RINTATOLIMOD","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ampligen"],"synonyms":["Atvogen","Poly i : poly c12u","Poly i: poly c12u","Rintatolimod"],"linkedTargets":{"rows":["ENSG00000164342"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","EFO_0001423","MONDO_0004658","MONDO_0100096","EFO_0006861","MONDO_0015686","EFO_0000756","EFO_0000764","MONDO_0008170","EFO_0000673","MONDO_0007254","MONDO_0044881","EFO_0004540"],"count":13},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL2107870","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"PEGNIVACOGIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pegnivacogin","RB-006","RB006","REG-1","REG1"],"linkedTargets":{"rows":["ENSG00000101981"],"count":1},"linkedDiseases":{"rows":["EFO_0001645","EFO_0005672"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108131","drugType":"Unknown","blackBoxWarning":false,"name":"PLASMINOGEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Human plasminogen","Plasma trypsinogen","Plasminogen","Profibrinolysin"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108311","drugType":"Enzyme","blackBoxWarning":false,"name":"ASFOTASE ALFA","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Strensiq"],"synonyms":["ALXN-1215","ALXN1215","Asfotase alfa","ENB-0040"],"crossReferences":{"DailyMed":["asfotase%20alfa"],"DrugCentral":["5049"]},"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for hypophosphatasia."}
{"id":"CHEMBL2108431","drugType":"Antibody","blackBoxWarning":false,"name":"METELIMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CAT-192","Metelimumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108474","drugType":"Antibody","blackBoxWarning":false,"name":"MASLIMOMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Maslimomab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109198","drugType":"Unknown","blackBoxWarning":false,"name":"METHYLCELLULOSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Celevac","Cellucon","Citrucel","Cologel","Methocel a","Nilstim"],"synonyms":["Benecel mc a15c","Cellulose methyl ether","E-461","FEMA NO. 2696","INS NO.461","INS-461","Methycellulose","Methyl ether of cellulose","Methylcellulose","Methylcellulose (1500 cps)","Methylcellulose (1500 mpa.s)","Methylcellulose 1500","Methylcellulose, unspecified","Methylcelluloses","Methylcellulosum","Metolose sm 1500"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for constipation and has 2 investigational indications."}
{"id":"CHEMBL2109279","drugType":"Antibody","blackBoxWarning":false,"name":"RG-7598","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DFRF4539A","RG-7598"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109288","drugType":"Antibody","blackBoxWarning":false,"name":"BIVATUZUMAB MERTANSINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIWA-1-DM1","Bivatuzumab mertansine","Biwa-4 mertansine"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109351","drugType":"Antibody","blackBoxWarning":false,"name":"FBT-A05","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FBT-A05"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109372","drugType":"Antibody","blackBoxWarning":false,"name":"MEDI-565","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MEDI-565","Medi-565"],"linkedTargets":{"rows":["ENSG00000105388","ENSG00000198851"],"count":2},"linkedDiseases":{"rows":["EFO_0000228"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109430","drugType":"Antibody","blackBoxWarning":false,"name":"GIMSILUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gimsilumab","MORAb-022"],"linkedTargets":{"rows":["ENSG00000164400"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0100096"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2109667","drugType":"Antibody","blackBoxWarning":false,"name":"SIMTUZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AB-0024","AB0024","GS-6624","Simtuzumab"],"linkedTargets":{"rows":["ENSG00000134013"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001422","EFO_0002618","EFO_0004268","MONDO_0044903","EFO_0000768","EFO_1001951"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL2109678","drugType":"Antibody","blackBoxWarning":false,"name":"HUJ591 177LU","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HUJ591","Huj591 (177lu)","Huj591 177lu"],"linkedTargets":{"rows":["ENSG00000086205"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2110730","canonicalSmiles":"CSCC[C@H](N)C(=O)N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2[C@H](C(=O)O)[C@H]21","inchiKey":"VOYCNOJFAJAILW-CAMHOICYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POMAGLUMETAD METHIONIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2140023","LY-2140023 MONOHYDRATE","LY2140023","Ly2140023","Pomaglumetad methionil"],"childChemblIds":["CHEMBL2105707"],"linkedTargets":{"rows":["ENSG00000164082","ENSG00000198822"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090","EFO_0005407","EFO_0001358","EFO_0004701"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2110780","canonicalSmiles":"CC(C)(C)NCC(O)c1ccc(O)c(NC(N)=O)c1","inchiKey":"KEMXXQOFIRIICG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBUTEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carbuterol"],"crossReferences":{"drugbank":["DB13625"]},"childChemblIds":["CHEMBL2106022"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2111108","canonicalSmiles":"N=C(N)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1","inchiKey":"NHKZSTHOYNWEEZ-AFCXAGJDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARIBAVIRIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taribavirin"],"crossReferences":{"drugbank":["DB06408"]},"childChemblIds":["CHEMBL2107375"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2159122","canonicalSmiles":"COc1ccc(CN(C(=O)[C@@H](N)Cc2c(C)cc(C(N)=O)cc2C)[C@@H](C)c2nc(-c3ccccc3)c[nH]2)cc1C(=O)O","inchiKey":"QFNHIDANIVGXPE-FNZWTVRRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELUXADOLINE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Truberzi","Viberzi"],"synonyms":["Eluxadoline","JNJ-27018966"],"crossReferences":{"DailyMed":["eluxadoline"],"drugbank":["DB09272"],"chEBI":["85980"]},"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","HP_0004798"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for irritable bowel syndrome."}
{"id":"CHEMBL2347704","canonicalSmiles":"CC1(C)OB(O)c2cc(NC(=O)c3ccc(F)cc3C(F)(F)F)ccc21","inchiKey":"PTYGDEXEGLDNAZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACOZIBOROLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acoziborole","SCTX-7158","SCYX-7158","Scyx-7158"],"crossReferences":{"drugbank":["DB13086"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2348292","canonicalSmiles":"O=C(O)CCc1cc(I)c(Oc2ccc(O)cc2)c(I)c1","inchiKey":"WONYMNWUJVKVII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,5-DIIODOTHYROPROPIONIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,5-diiodothyropropionic acid","Ditpa"],"crossReferences":{"drugbank":["DB12629"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL235363","canonicalSmiles":"CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N)C(N)=O","inchiKey":"ADNPLDHMAVUMIW-CUZNLEPHSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SUBSTANCE P","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Neurokinin p","Neuropeptide sp-1","Sh-oligopeptide-73","Substance p","Substance p (1-11)"],"crossReferences":{"PubChem":["50112420"],"Wikipedia":["Substance_P"]},"description":"Protein drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2364619","canonicalSmiles":"C[N@+]1(CC2CC2)CC[C@]23CC(=O)CC[C@@]2(O)[C@H]1Cc1ccc(C(N)=O)c(O)c13","inchiKey":"ATCVVCBJNHXIEX-ZAHKBLQYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYLSAMIDORPHAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALKS 37","ALKS-37 CATION","Methylsamidorphan","Methylsamidorphan cation","Methylsamidorphan ion","RDC-1036 CATION","RDC-1036-00","RDC-103600","RDC-103603","Rdc-1036"],"crossReferences":{"drugbank":["DB15241"]},"childChemblIds":["CHEMBL2364620"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["HP_0002019"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL243731","canonicalSmiles":"O=C(O)COc1c(C(=O)O)sc(-c2cccc(NCc3ccccc3)c2)c1Br","inchiKey":"XEQPGVUGYAUMSA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL243731","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07289"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24983","canonicalSmiles":"O=c1oc(Cl)c(Cl)c2ccccc12","inchiKey":"SUGXUUGGLDCZKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,4-Dichloroisocoumarin","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4-Dichloroisocoumarin"],"crossReferences":{"PubChem":["11111099","26753564","50106222","57264275","85231012","90341353"],"drugbank":["DB04459"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL268254","canonicalSmiles":"O=C1CN=C(c2ccccc2Cl)c2cc(Cl)ccc2N1","inchiKey":"CHIFCDOIPRCHCF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELORAZEPAM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chlordesmethyldiazepam","Dadumir","Delorazepam","NSC-169895"],"crossReferences":{"Wikipedia":["Delorazepam"],"drugbank":["DB01511"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275528","canonicalSmiles":"c1ccc(C2(N3CCCCC3)CCCCC2)cc1","inchiKey":"JTJMJGYZQZDUJJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENCYCLIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Angel dust","J4.441E","Phencyclidine","Phencycline","Phenylcyclidine"],"crossReferences":{"Wikipedia":["Phencyclidine"],"drugbank":["DB03575"],"chEBI":["8058"]},"childChemblIds":["CHEMBL542581"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL276518","canonicalSmiles":"C1COCCN1","inchiKey":"YNAVUWVOSKDBBP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MORPHOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Morpholine"],"crossReferences":{"PubChem":["144209648","144213557"],"Wikipedia":["Morpholine"],"drugbank":["DB13669"],"chEBI":["34856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL278020","canonicalSmiles":"CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1","inchiKey":"ALWKGYPQUAPLQC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEOSTIGMINE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Miostin","Neostigmine","Neostigmine (cation)","Neostigmine cation","Neostigmine hydroxide","Neostigmine ion"],"crossReferences":{"DailyMed":["neostigmine%20methylsulfate"],"PubChem":["11111527","11111528","26756597","90340848"],"drugbank":["DB01400"],"chEBI":["7514"]},"childChemblIds":["CHEMBL211471","CHEMBL54126"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0001074","EFO_0004210","HP_0002093","EFO_0005323","EFO_0001645","MONDO_0007254","MONDO_0004567","EFO_0009516","EFO_0009267","EFO_0001073","EFO_0003843","HP_0002315","MONDO_0001187","EFO_0002950","EFO_0007149","EFO_0001422","EFO_0004888","EFO_0004209","EFO_0000341","EFO_0004991","HP_0003270","EFO_0000516","EFO_0003918","GO_0007596","HP_0025267","HP_0003470"],"count":26},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for glaucoma and myasthenia gravis and has 8 investigational indications."}
{"id":"CHEMBL278785","canonicalSmiles":"O=C(O)[C@H](Cc1ccccc1)N(Cc1ccc(-c2cc3ccccc3o2)s1)C(=O)c1ccc(Cl)cc1Cl","inchiKey":"YBULOUKTPCHXAL-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL278785","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02331"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL284314","canonicalSmiles":"C=CCN1C(=O)N(CC=C)[C@H](Cc2ccccc2)[C@H](O)[C@@H](O)[C@H]1Cc1ccccc1","inchiKey":"IWJSQELMWLOYSO-LWSSLDFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL284314","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06910"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039505","canonicalSmiles":"CC(C)(C)c1ccc(S(=O)(=O)[N-]c2ccc(Cl)cc2C(=O)c2cc[n+]([O-])cc2)cc1.[Na+]","inchiKey":"RWWYDQSZJIFTES-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"VERCIRNON SODIUM","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2178578","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-1605786A","GSK1605786A","Vercirnon sodium"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3137346","drugType":"Enzyme","blackBoxWarning":false,"name":"PEGARGIMINASE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["0B7PYQ9YRT","ADI-PEG","ADI-PEG 20","ADI-PEG-20","ADI-PEG20","ADI-SS","ADIPEG20","PEG 20","Pegargiminase","Pegylated arginine deiminase"],"description":"Enzyme drug with a maximum clinical trial phase of II (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL32113","canonicalSmiles":"COc1ccc(OC)c(CN(C)c2cnc3nc(N)nc(N)c3c2)c1","inchiKey":"HZTFNSCZLJLPEO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL32113","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02583"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301577","drugType":"Protein","blackBoxWarning":false,"name":"IPAFRICEPT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ipafricept","OMP-54F28"],"linkedTargets":{"rows":["ENSG00000177283"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3351077","canonicalSmiles":"NC(=O)c1cc[n+](CC2=C(C(=O)O)N3C(=O)[C@@H](NC(=O)[C@@H](c4ccccc4)S(=O)(=O)[O-])[C@H]3SC2)cc1","inchiKey":"SYLKGLMBLAAGSC-QLVMHMETSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFSULODIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cefsulodin","J01DD03"],"crossReferences":{"drugbank":["DB13499"],"chEBI":["3507"]},"childChemblIds":["CHEMBL1590946","CHEMBL4303721"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL3545084","drugType":"Small molecule","blackBoxWarning":false,"name":"TCD-717","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tcd-717"],"linkedTargets":{"rows":["ENSG00000110721"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545173","drugType":"Small molecule","blackBoxWarning":false,"name":"IRX4310","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Irx4310"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545214","drugType":"Small molecule","blackBoxWarning":false,"name":"AXP-107-11","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Axp-107-11"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707222","canonicalSmiles":"CCCC[C@]1(CC)CS(=O)(=O)c2ccc(N(C)C)cc2[C@@H](c2cccc(NC(=O)N[C@@H]3O[C@H](COS(=O)(=O)O)[C@@H](O)[C@H](OCc4ccccc4)[C@H]3O)c2)[C@H]1O","inchiKey":"ULVBLFBUTQMAGZ-RTNCXNSASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOLIXIBAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SAR-548304 FREE ACID","Volixibat"],"crossReferences":{"drugbank":["DB13914"]},"childChemblIds":["CHEMBL3956446","CHEMBL3707221"],"linkedTargets":{"rows":["ENSG00000125255"],"count":1},"linkedDiseases":{"rows":["EFO_0004268","MONDO_0019072","EFO_1001486"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL372357","canonicalSmiles":"O=c1c(C2=Nc3ccccc3S(=O)(=O)N2)c(O)c2cc(F)ccc2n1CCC1CC1","inchiKey":"QEMCDXCXSVPAAB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL372357","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08278"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL378544","canonicalSmiles":"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1.O=S(=O)(O)O","inchiKey":"KDQAABAKXDWYSZ-PNYVAJAMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VINBLASTINE SULFATE","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL159","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Velban","Velbe","Vinblast,lederle","Vinblastine sulfate"],"synonyms":["29060-LE","29060LE","Alkaban-aq","NSC-49842","Vinblastine sulfate","Vinblastine sulphate","Vinblastini sulfas","Vincaleukoblastine sulfate","Vlb monosulfate"],"crossReferences":{"DailyMed":["vinblastine%20sulfate"],"PubChem":["144205051","144206288","170464976","170464977","26663016","56462989","855758"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["MONDO_0009348","EFO_0004281","MONDO_0003751","EFO_0001642","EFO_0000756","MONDO_0008170","EFO_0009907","MONDO_0004192","MONDO_0002041","MONDO_0004986","MONDO_0008315","EFO_0003060","MONDO_0020654","MONDO_0001187","EFO_0000588","MONDO_0018201","MONDO_0002974","EFO_0000389","MONDO_0008903","EFO_0000574","MONDO_0002367","EFO_0006544","EFO_0000183","EFO_0000691"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 5 approved and 15 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3809489","canonicalSmiles":"Nc1nc(Nc2ccc3c(c2)CC[C@@H](N2CCCC2)CC3)nn1-c1cc2c(nn1)-c1ccccc1CCC2","inchiKey":"KXMZDGSRSGHMMK-VWLOTQADSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEMCENTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB 324","BGB-324","BGB324","Bemcentinib","CS-1046","HY-15150","KB-80319","QC-11751","R 428","R-428","R428","SYN-1131","SYN1131","W-5845"],"crossReferences":{"drugbank":["DB12411"]},"linkedTargets":{"rows":["ENSG00000167601"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0002618","MONDO_0100096","EFO_0000588","EFO_0000756","EFO_0000571","EFO_0000222","EFO_0003060","EFO_1000984","EFO_1000158"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL3833302","canonicalSmiles":"C/C=C/C(=O)N(CC)C(CC)C(=O)N(C)C.C/C=C/C(=O)N(CCC)C(CC)C(=O)N(C)C","inchiKey":"ZDHWSRRZUPRQBD-ACOOBTJJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRETHCAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["G-5668","Gycoren","Miconen","Micoren","Prethcamide","Respirot"],"crossReferences":{"DrugCentral":["4333"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3930624","canonicalSmiles":"O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCn2nc(C(F)(F)F)nc2C1","inchiKey":"XJGXCBHXFWBOTN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUZOPARIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluzoparib","Fuzuloparib","Fuzuopali","HS-10160","HS10160","SHR-3162","SHR3162","Shr3162"],"crossReferences":{"drugbank":["DB15637"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 13 investigational indications."}
{"id":"CHEMBL3989916","canonicalSmiles":"C/C=C(\\C)C(=O)O[C@@H]1[C@@H](C)[C@]2(O)[C@@H]3C=C(C)C(=O)[C@@]3(O)[C@H](O)[C@@]3(CO)O[C@H]3[C@H]2[C@@H]2C(C)(C)[C@]12OC(=O)[C@@H](C)CC","inchiKey":"YLQZMOUMDYVSQR-FOWZUWBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIGILANOL TIGLATE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EBC-46","EBI-46","Tigilanol tiglate"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL41036","canonicalSmiles":"CC(C)c1cc(Oc2c(Cl)cc(CC(=O)O)cc2Cl)ccc1O","inchiKey":"OZYQIQVPUZANTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL41036","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03176"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL410462","canonicalSmiles":"COC(=O)[C@@]1(Cc2ccc(OCc3cc(C)nc4ccccc34)cc2)C[C@@H]1C(=O)NO","inchiKey":"HJWMYFBKJRVWJY-YKSBVNFPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL410462","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07147"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL411274","canonicalSmiles":"O=P(O)(O)C(O)(Cc1cccc(-c2cccc3c2oc2ccccc23)c1)P(=O)(O)O","inchiKey":"BYVXAUZOTGITQZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BPH-629","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BPH-629"],"crossReferences":{"drugbank":["DB07410"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4113131","canonicalSmiles":"C[C@H]1CN(C(=O)c2ccc(NC(=O)c3cc(O[C@H](C)c4c(Cl)ccc(F)c4Cl)c(N)nn3)cc2)C[C@@H](C)N1","inchiKey":"GLYMPHUVMRFTFV-QLFBSQMISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENSARTINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ensartinib","X-396"],"crossReferences":{"drugbank":["DB14860"]},"childChemblIds":["CHEMBL4297219"],"linkedTargets":{"rows":["ENSG00000171094"],"count":1},"linkedDiseases":{"rows":["EFO_0000756","MONDO_0008903","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL42403","canonicalSmiles":"OB(O)O","inchiKey":"KGBXLFKZBHKPEV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BORIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Boracic acid","Boric Acid","Boric acid","Boric acid (bh3o3)","Boric acid (h(sub 3)bo(sub 3))","Boricum acidum","E-284","E284","INS NO.284","INS-284","NSC-81726","Nci-c56417"],"crossReferences":{"PubChem":["144204555","144209383","144211317","17390008","26752774"],"Wikipedia":["Boric_acid"],"drugbank":["DB11326"],"chEBI":["33118"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297190","canonicalSmiles":"Cc1cc2cc(Oc3ccnc(Nc4cccc(CS(=O)(=O)NCCN(C)C)c4)n3)ccc2[nH]1","inchiKey":"TTZSNFLLYPYKIL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SURUFATINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HMPL-012","Hmpl-012","Sulfatinib","Surufatinib"],"crossReferences":{"drugbank":["DB15106"]},"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000077782"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0003060","EFO_0003086","EFO_0006859","EFO_0002618","EFO_0000503","EFO_1001901","MONDO_0002108","MONDO_0007254","EFO_0005842","EFO_0004252","EFO_0003060","EFO_1001951","EFO_1001961","MONDO_0002120","EFO_0002892","EFO_0000182","EFO_0001421","EFO_0000702","EFO_0000691"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL4297377","canonicalSmiles":"CCC(=O)[N-]S(=O)(=O)c1ccc(NC(=O)Cc2ccc(Br)c(Oc3cc(Cl)cc(C#N)c3)c2F)c(Cl)c1.[Na+]","inchiKey":"UJFARQSHFFWJHD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ELSULFAVIRINE SODIUM","maximumClinicalTrialPhase":1,"parentId":"CHEMBL4301163","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elpida","Elsulfavirine sodium","R-1206 SODIUM","R1206(SODIUM SALT)"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297394","canonicalSmiles":"C=C(C#N)C(=O)OCCC(C)C","inchiKey":"GASDVTHQNCFANM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPENTYL 2-CYANOACRYLATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Isoamyl 2-cyanoacrylate","Isopentyl 2-cyanoacrylate"],"crossReferences":{"drugbank":["DB12630"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297455","canonicalSmiles":"O=C(O)Cc1nn(Cc2nc3cc(C(F)(F)F)ccc3s2)c(=O)c2nccnc12","inchiKey":"YRGPAXAVTDMKDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AT-001","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AT-001","Aldose reductase-in-1","At-001","Caficrestat"],"crossReferences":{"drugbank":["DB15121"]},"linkedTargets":{"rows":["ENSG00000085662"],"count":1},"linkedDiseases":{"rows":["MONDO_0100096","EFO_1001905"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297509","canonicalSmiles":"CCNCCc1ccc(CN(CC)c2cc(OC)ccc2[C@@H]2CCc3cc(O)ccc3C2)cc1","inchiKey":"SIFNOOUKXBRGGB-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELACESTRANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ER-306323","Elacestrant","RAD-1901","RAD1901","Rad1901"],"crossReferences":{"drugbank":["DB06374"]},"childChemblIds":["CHEMBL4594273"],"linkedTargets":{"rows":["ENSG00000091831"],"count":1},"linkedDiseases":{"rows":["MONDO_0007254","HP_0031217","EFO_0000305"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297573","drugType":"Protein","blackBoxWarning":true,"name":"TAGRAXOFUSP","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elzonris"],"synonyms":["DT-3881L3","DT388IL3","MOLECULE-129","Molecule 129","SL-401","Sl-401","Tagraxofusp","Tagraxofusp-erzs"],"crossReferences":{"DailyMed":["tagraxofusp-erzs"]},"linkedTargets":{"rows":["ENSG00000167658","ENSG00000185291"],"count":2},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_1001779","EFO_0000222","EFO_0010580"],"count":5},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for neoplasm and acute myeloid leukemia and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL4297654","canonicalSmiles":"N=C(N)NC(=N)N","inchiKey":"XNCOSPRUTUOJCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIGUANIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Biguanide"],"crossReferences":{"drugbank":["DB13100"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL432359","canonicalSmiles":"CC(=O)N[C@@H](Cc1ccc(CC(=O)O)c(C(=O)O)c1)C(=O)N[C@H]1CCCCN(Cc2ccc(-c3ccccc3)cc2)C1=O","inchiKey":"CEKLBQMULVLLTD-VMPREFPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL432359","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03712"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL441738","canonicalSmiles":"CCCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C","inchiKey":"UAHFGYDRQSXQEB-LEBBXHLNSA-N","drugType":"Protein","blackBoxWarning":false,"name":"AFAMELANOTIDE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Scenesse"],"synonyms":["Afamelanotide","CUV-1647","CUV1647","Melanotan i","Melanotan-1"],"crossReferences":{"DailyMed":["afamelanotide"],"Wikipedia":["Afamelanotide"],"drugbank":["DB04931"]},"childChemblIds":["CHEMBL4297213"],"linkedTargets":{"rows":["ENSG00000258839"],"count":1},"linkedDiseases":{"rows":["EFO_0005531","HP_0002140","EFO_0004208","MONDO_0041182","Orphanet_910","EFO_0003894","Orphanet_79278"],"count":7},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for erythropoietic protoporphyria and has 4 investigational indications."}
{"id":"CHEMBL451721","canonicalSmiles":"CCCCC[C@H](O)/C=C/C=C\\CCCCCCCC(=O)O","inchiKey":"HNICUWMFWZBIFP-IRQZEAMPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-Coriolic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Coriolic Acid"],"crossReferences":{"PubChem":["26754875","26754876"],"drugbank":["DB06926"],"chEBI":["34154"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL459170","canonicalSmiles":"Cc1cc(C#N)cc(Oc2ccc(Cc3n[nH]c4nnccc34)cc2Br)c1","inchiKey":"YYGZQXRLQMFHDH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL459170","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08444"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594269","canonicalSmiles":"CN(C)CC1CCOC1(c1ccccc1)c1ccccc1.Cl","inchiKey":"FEQOLYDPQKHFTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BLARCAMESINE HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL4297224","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Anavex"],"synonyms":["AE-37 hydrochloride","ANA001-HCl","ANAVEX 2-73 HYDROCHLORIDE","ANAVEX-2-73 HYDROCHLORIDE","ANAVEX2-73","ANAVEX2-73 HYDROCHLORIDE","Blarcamesine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594298","canonicalSmiles":"COc1cc2c(cc1OC)CN(CCc1ccc(-n3nnc(-c4cc(OC)c(OC)cc4NC(=O)c4cc(=O)c5ccccc5o4)n3)cc1)CC2","inchiKey":"AHJUHHDDCJQACA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENCEQUIDAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Encequidar","HM-30181","HM30181","HM30181AK","Pgp inhibitor hm30181ak"],"childChemblIds":["CHEMBL4594299"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594362","drugType":"Unknown","blackBoxWarning":false,"name":"SAPOSIN C (NON-GLYCOSYLATED)","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BXQ-350","Bxq-350","Saposin c (non-glycosylated)","Saposin c recombinant"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594542","drugType":"Protein","blackBoxWarning":false,"name":"EFLEPEDOCOKIN ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Eflepedocokin alfa","F-652","Il-22 dimer f-652","Promenakin"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4596392","canonicalSmiles":"CNC(=O)c1nnc(NC(=O)C2CC2)cc1Nc1cccc(-c2ncn(C)n2)c1OC","inchiKey":"BZZKEPGENYLQSC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEUCRAVACITINIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4435170"],"linkedTargets":{"rows":["ENSG00000105397"],"count":1},"linkedDiseases":{"rows":["EFO_0003834","EFO_0003086","EFO_0000729","EFO_0005761","EFO_0002690","MONDO_0004670","HP_0001410","EFO_0003778","EFO_0000676","EFO_0000540"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL463981","canonicalSmiles":"O=S(=O)(N[C@H](CO)C(C(F)(F)F)C(F)(F)F)c1ccc(Cl)s1","inchiKey":"PSXOKXJMVRSARX-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEGACESTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Begacestat","GSI-953"],"crossReferences":{"drugbank":["DB12263"]},"linkedTargets":{"rows":["ENSG00000205155","ENSG00000138613","ENSG00000162736","ENSG00000080815","ENSG00000143801","ENSG00000117362"],"count":6},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650335","canonicalSmiles":"COc1cc2cc(c1Cl)N(C)C(=O)C[C@H](OC(=O)[C@H](C)N(C)C(=O)CCSSC[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc3ccccc3)C(=O)N[C@@H](Cc3ccc(O)cc3)C(=O)N[C@H](Cc3c[nH]c4ccccc34)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1)C(N)=O)[C@]1(C)O[C@H]1[C@H](C)[C@@H]1C[C@@](O)(NC(=O)O1)[C@H](OC)/C=C/C=C(\\C)C2","inchiKey":"JVPMJFUBODFGNB-UFDFPQQFSA-N","drugType":"Protein","blackBoxWarning":false,"name":"NENDRATAREOTIDE UZATANSINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nendratareotide uzatansine","Pen-221"],"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650432","drugType":"Unknown","blackBoxWarning":false,"name":"ZIRCONIUM ZR-89-DESFERRIOXAMINE-IAB22M2C","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["89ZR-DF-IAB22M2C","89zr-df-iab22m2c","Zirconium zr 89-df-iab22m2c","Zirconium zr-89-desferrioxamine-iab22m2c"],"description":"Unknown drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650503","drugType":"Unknown","blackBoxWarning":false,"name":"ANDROSTA-4,16-DIEN-3-OL, (3.BETA.)-","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-androstadienol","Aloradine","Androsta-4,16-dien-3-ol, (3.beta.)-","PH94B","Ph94b"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4651180","canonicalSmiles":"COc1ccc(-c2c(-c3ccc(C#N)c(F)c3)nc(N3CCC(N)CC3)n(C)c2=O)cc1F","inchiKey":"NBAIXBAUHIQQGF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PULRODEMSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4650360"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL478858","canonicalSmiles":"CCCCCCCCN1CCc2c(C)c(CC(=O)O)c(C)c(NC(=O)C(C)(C)C)c21","inchiKey":"TXIIZHHIOHVWJD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PACTIMIBE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pactimibe"],"crossReferences":{"drugbank":["DB12971"]},"childChemblIds":["CHEMBL564483","CHEMBL447977"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL485652","canonicalSmiles":"Cc1cn([C@H]2C=C[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"ODSQODTUNULBHF-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STAVUDINE TRIPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D4ttp","Stavudine triphosphate"],"crossReferences":{"drugbank":["DB02887"]},"childChemblIds":["CHEMBL320969"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL48813","canonicalSmiles":"N=C(N)c1ccc(CN2CCN(S(=O)(=O)c3cc4ccc(Cl)cc4s3)CC2=O)cc1","inchiKey":"VXONTEUOQXFJJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL48813","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08495"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL500826","canonicalSmiles":"CCC(=O)[O-].[Na+]","inchiKey":"JXKPEJDQGNYQSM-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM PROPIONATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E281","Sodium Propionate"],"crossReferences":{"DrugCentral":["4796"],"PubChem":["144206595","144209933"],"Wikipedia":["Sodium_propionate"]},"childChemblIds":["CHEMBL3989705"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL509064","canonicalSmiles":"O=C(O)CNC(=O)c1ncc2c(I)cccc2c1O","inchiKey":"FUMNLXHPILGSLC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL509064","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07112"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54440","canonicalSmiles":"CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21","inchiKey":"AJLFOPYRIVGYMJ-INTXDZFKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEVASTATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mevastatin","NSC-759322"],"crossReferences":{"PubChem":["144205093","24820212","26719712","89850273","90340823"],"Wikipedia":["Mevastatin"],"drugbank":["DB06693"],"chEBI":["34848"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL55771","canonicalSmiles":"C[C@@H](NC(=O)c1ccccc1)C(=O)O","inchiKey":"UAQVHNZEONHPQG-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-Benzoylamino-Propionic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Benzoylamino-Propionic Acid","Benzoyl-D-Alanine"],"crossReferences":{"drugbank":["DB08508"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL566534","canonicalSmiles":"CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3","inchiKey":"SXYIRMFQILZOAM-HVNFFKDJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTEMETHER","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Artemetheri"],"synonyms":[".beta.-artemether","Artemether","Artemetherum","Artesaph","Dihydroartemisinin impurity g","Falcidol","Gvither","Larither","Malartem","NSC-665970","NSC-759820","Paluther","SM 224"],"crossReferences":{"DailyMed":["artemether"],"PubChem":["124893169","26758013"],"drugbank":["DB06697"],"chEBI":["195280"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and is indicated for malaria and has 6 investigational indications."}
{"id":"CHEMBL57053","canonicalSmiles":"Oc1ccc(Cl)cc1","inchiKey":"WXNZTHHGJRFXKQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARACHLOROPHENOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Parachlorophenol"],"crossReferences":{"PubChem":["144204579","144208902","144213177","170465673","17389609","85272562"],"drugbank":["DB13154"],"chEBI":["28078"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL584852","canonicalSmiles":"CCOC(=O)c1cnc2cc(OCC(C)C)c(OCC(C)C)cc2c1O","inchiKey":"LVVXOXRUTDAKFE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUQUINOLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Buquinolate","EU-1093","GNF-PF-1188","NSC-201116"],"crossReferences":{"PubChem":["144206110","50112816"],"drugbank":["DB11378"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL590540","canonicalSmiles":"N[C@@H](CSSC[C@H](N)C(=O)O)C(=O)O","inchiKey":"LEVWYRKDKASIDU-IMJSIDKUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYSTINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cystine","NSC-13203"],"crossReferences":{"PubChem":["144205715","170465457","29217764"],"drugbank":["DB00138"],"chEBI":["16283"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL590754","canonicalSmiles":"COc1ccc(/C(C)=N/OC(N)=O)cc1OC1CCCC1","inchiKey":"STTRYQAGHGJXJJ-LICLKQGHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FILAMINAST","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Filaminast","WAY-PDA-641"],"crossReferences":{"drugbank":["DB02660"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL66115","canonicalSmiles":"Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1","inchiKey":"CKTSBUTUHBMZGZ-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYCYTIDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxycytidine","Deoxycytidine","Doxecitine"],"crossReferences":{"PubChem":["26754278"],"Wikipedia":["Deoxycytidine"],"drugbank":["DB02594"],"chEBI":["15698"]},"childChemblIds":["CHEMBL1356971","CHEMBL1873101"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL683","canonicalSmiles":"CC(C)(Oc1ccc(Cl)cc1)C(=O)O","inchiKey":"TXCGAZHTZHNUAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFIBRIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clofibric Acid","Clofibric acid","NSC-1149"],"crossReferences":{"PubChem":["11112452","11113721","124882396","144204037","144211997","170466427","26747130","26751908","51085303"],"Wikipedia":["Clofibric_acid"],"chEBI":["34648"]},"childChemblIds":["CHEMBL3833336","CHEMBL2106803","CHEMBL2106625","CHEMBL3392241"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL70176","canonicalSmiles":"COc1ccc(S(=O)(=O)N(Cc2cccnc2)c2c(C)cccc2C(=O)NO)cc1","inchiKey":"AINJYWXKBKRQSX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL70176","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02071"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL716","canonicalSmiles":"OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1","inchiKey":"URKOMYMAXPYINW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"QUETIAPINE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Atrolak xl","Biquelle xl","Brancico xl","Ebesque xl","Mintreleq xl","Psyquet xl","Seotiapim xl","Seroquel","Seroquel xl","Sondate xl","Tenprolide xl","Zaluron xl"],"synonyms":["NSC-758918","Norsic","Quetiapine","Quetiapine extended release"],"crossReferences":{"DailyMed":["quetiapine%20fumarate"],"PubChem":["144205090","170465146","26749928","29215183","49666155"],"Wikipedia":["Quetiapine"],"drugbank":["DB01224"],"chEBI":["8707"]},"childChemblIds":["CHEMBL1200911","CHEMBL3188993"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468","ENSG00000147246"],"count":3},"linkedDiseases":{"rows":["MONDO_0004938","MONDO_0005090","EFO_0005687","EFO_0004262","EFO_0002610","MONDO_0002009","HP_0000726","EFO_0007453","EFO_0009267","EFO_1001917","EFO_0004698","MONDO_0002046","EFO_0007191","EFO_0004247","EFO_0000289","MONDO_0002050","MONDO_0005180","EFO_0003884","EFO_0004257","EFO_0003761","EFO_0009854","EFO_0004701","EFO_0004242","MONDO_0007079","EFO_0005230","EFO_0009964","EFO_0004215","EFO_0003888","HP_0012076","EFO_0000677","EFO_1000904","EFO_0009963","EFO_0005407","EFO_0001358","EFO_1001918","HP_0000713","EFO_1001892","EFO_0003890","MONDO_0002491","Orphanet_79292","MONDO_0005301","EFO_0005411"],"count":42},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and has 8 approved and 36 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL746","canonicalSmiles":"CCCc1c2oc(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)n(CC)c12","inchiKey":"RQTOOFIXOKYGAN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEDOCROMIL","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["FPL 59002","FPL-59002","Nedocromil"],"crossReferences":{"DailyMed":["nedocromil%20sodium"],"PubChem":["144206699","170464978"],"Wikipedia":["Nedocromil"],"drugbank":["DB00716"],"chEBI":["7492"]},"childChemblIds":["CHEMBL2105133","CHEMBL915"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 4 approved and 1 investigational indication."}
{"id":"CHEMBL77961","canonicalSmiles":"CC1(C)CCC(C)(C)c2cc(/C(=N\\O)c3ccc4cc(C(=O)O)ccc4c3)ccc21","inchiKey":"RNZIUDLOJHVHLZ-VYIQYICTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL77961","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02258"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL918","canonicalSmiles":"NC(=O)NC(=O)Cc1ccccc1","inchiKey":"XPFRXWCVYUEORT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENACEMIDE","yearOfFirstApproval":1951,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Phenurone"],"synonyms":["NSC-39458","Phenacemide"],"crossReferences":{"PubChem":["144204878","170465322","26748194"],"Wikipedia":["Phenacemide"],"drugbank":["DB01121"],"chEBI":["8049"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000474"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1951 and is indicated for epilepsy."}
{"id":"CHEMBL92608","canonicalSmiles":"CCOC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(=O)NO)CC(C)C","inchiKey":"XKRONJXEXGFBRZ-ZNMIVQPWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"Ro-31-4724","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ro-31-4724"],"crossReferences":{"drugbank":["DB08482"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
